SBTX Insider Trading Activity and SEC Form 4 Filings
SBTX insider trading summary
No open-market insider purchases or sales of Silverback Therapeutics, Inc. (SBTX) have been reported on SEC Form 4 in the past 12 months.
Latest SBTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 15, 2021 | Jonathan D Root | Director | Buy | $18K (2,014 @ $8.85) |
| Mar 3, 2021 | Jonathan D Root | Director | Buy | $18K (350 @ $52.07) |
| Dec 8, 2020 | Orbimed Capital LLC | Director | Buy | $5.0M (238,100 @ $21.00) |
| Dec 8, 2020 | Orbimed Advisors LLC | Director | Buy | $20.0M (952,377 @ $21.00) |
| Dec 8, 2020 | Orbimed Capital LLC | Director | Buy | $20.0M (952,377 @ $21.00) |
| Dec 8, 2020 | OrbiMed Capital GP VI LLC | Director | Buy | $20.0M (952,377 @ $21.00) |
| Dec 8, 2020 | Jonathan D Root | Director | Buy | $2.0M (95,238 @ $21.00) |
| Dec 8, 2020 | Vickie L Capps | Director | Buy | $200K (9,523 @ $21.00) |
| Dec 8, 2020 | Peter A. Thompson | Director | Buy | $5.0M (238,100 @ $21.00) |
| Dec 8, 2020 | Orbimed Advisors LLC | Director | Buy | $5.0M (238,100 @ $21.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.